The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs
✍ Scribed by David Vremec; Graham J. Lieschke; Ashley R. Dunn; Lorraine Robb; Donald Metcalf; Ken Shortman
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 521 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract We previously established 2 lung cancer cell lines, OKa‐C‐1 and MI‐4, which constitutively produce an abundant dose of granulocyte‐colony stimulating factor (G‐CSF) and granulocyte macrophage‐colony stimulating factor (GM‐CSF). Many other cases with G‐CSF or GM‐CSF producing tumors have
GM-CSF is a major regulator of myelopoiesis. Recombinant human GM-CSF (250 micrograms/m2 per day i.v.) was used prior to chemotherapy ("3 + 7" scheme) to recruit leukemic blasts in vivo (de novo AML patients, n = 20) into the chemotherapy sensitive phases of the cell cycle. The stimulatory effect of
## Abstract Spleen cells were collected from normal mice and cultured in a medium containing 20% calf serum. Addition of lipopolysaccharide (LPS) in the culture significantly increased the production of granulocyte‐macrophage colony‐stimulating factor (GM‐CSF), and a maximum induction was attained
Interleukin 1 and tumor necrosis factor-a additively increase the levels of granulocyte-macrophage and granulocyte colony-stimulating factor (CSF) mRNA in human fibroblasts\* Recombinant interleukin (IL) 1 p and tumor necrosis factorkachectin (TNF-a) induce, usually within 2 h, a dose-dependent incr